NO864022D0 - Infusjonsopploesninger av 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-kinolin-3-karboksylsyre. - Google Patents

Infusjonsopploesninger av 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-kinolin-3-karboksylsyre.

Info

Publication number
NO864022D0
NO864022D0 NO864022A NO864022A NO864022D0 NO 864022 D0 NO864022 D0 NO 864022D0 NO 864022 A NO864022 A NO 864022A NO 864022 A NO864022 A NO 864022A NO 864022 D0 NO864022 D0 NO 864022D0
Authority
NO
Norway
Prior art keywords
kinoline
piperazinyl
cyclopropyl
dihydro
oxo
Prior art date
Application number
NO864022A
Other languages
English (en)
Other versions
NO864022L (no
Inventor
Robert Frank Lammens
Hans Friedrich Mahler
Peter Serno
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6284294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO864022(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO864022D0 publication Critical patent/NO864022D0/no
Publication of NO864022L publication Critical patent/NO864022L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO864022A 1985-10-24 1986-10-09 Infusjonsopploesninger av 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-kinolin-3-karboksylsyre. NO864022L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853537761 DE3537761A1 (de) 1985-10-24 1985-10-24 Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Publications (2)

Publication Number Publication Date
NO864022D0 true NO864022D0 (no) 1986-10-09
NO864022L NO864022L (no) 1987-04-27

Family

ID=6284294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864022A NO864022L (no) 1985-10-24 1986-10-09 Infusjonsopploesninger av 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-kinolin-3-karboksylsyre.

Country Status (27)

Country Link
US (1) US4957922A (no)
EP (1) EP0219784B1 (no)
JP (1) JPH0714879B2 (no)
KR (1) KR940002664B1 (no)
AR (1) AR244085A1 (no)
AT (1) ATE59003T1 (no)
AU (1) AU571796B2 (no)
CA (1) CA1282006C (no)
CY (1) CY1729A (no)
DD (1) DD252125A5 (no)
DE (2) DE3537761A1 (no)
DK (1) DK175494B1 (no)
ES (1) ES2021571B3 (no)
FI (1) FI84555C (no)
GR (1) GR3002544T3 (no)
HK (1) HK115593A (no)
HU (1) HUT42952A (no)
IE (1) IE59385B1 (no)
IL (1) IL80380A (no)
NO (1) NO864022L (no)
NZ (1) NZ218016A (no)
PH (1) PH26419A (no)
PL (1) PL152336B1 (no)
PT (1) PT83588B (no)
SU (1) SU1487801A3 (no)
UA (1) UA8033A1 (no)
ZA (1) ZA868057B (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281596A (en) * 1986-02-19 1994-01-25 Bayer Aktiengesellschaft Antibacterial drugs for fish
JPS62192321A (ja) * 1986-02-19 1987-08-22 Bayer Japan Kk 魚類用抗菌剤
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
US6300361B1 (en) * 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
FR2681863B1 (fr) * 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
ES2088742B1 (es) 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
US5800833A (en) * 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
MX9701731A (es) * 1995-06-06 1997-10-31 Bayer Ag Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.
IT1280428B1 (it) * 1995-07-14 1998-01-20 R R A S R L Composizione farmaceutica per uso topico
ES2106680B1 (es) * 1995-08-03 1998-07-01 Vita Invest Sa Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
DE19730023A1 (de) * 1997-07-11 1999-01-14 Bayer Ag Hochreine Ciprofloxacin-Infusion
JP2001521002A (ja) * 1997-10-24 2001-11-06 コーネル リサーチ ファンデーション インク． 脳の代謝機能不全のための栄養補充剤
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE10018783A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
ES2305065T3 (es) * 2000-04-24 2008-11-01 Daiichi Sankyo Company, Limited Preparacion liquida estable que contiene sitafloxacina.
DE10048510A1 (de) * 2000-09-29 2002-05-16 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
US6861422B2 (en) * 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004005186B3 (de) * 2004-02-02 2005-10-13 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von gereinigtem Ciprofloxacin
WO2005123137A2 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Lyophilized pharmaceutical composition comprising moxifloxacin hydrochloride
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
EP1827498A2 (de) * 2004-12-09 2007-09-05 Bayer HealthCare AG Stabilisierung von glucocorticoidestern mit säuren
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
TW200900066A (en) * 2007-03-22 2009-01-01 Daiichi Sankyo Co Ltd Quinolone medical composition containing alcohols
WO2008127060A1 (en) * 2007-04-13 2008-10-23 Dong Wha Pharmaceutical Co. Ltd. Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
JP5217276B2 (ja) * 2007-07-19 2013-06-19 ニプロ株式会社 注射用抗菌剤の製造方法
CA2695406A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
KR101646324B1 (ko) * 2014-03-04 2016-08-05 동화약품주식회사 1-시클로프로필-6-플루오로-7-(8-메톡시이미노-2,6-디아자-스피로[3,4]옥트-6-일)-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 디-아스파르트산염의 수화물 및 이를 포함하는 항균활성 조성물
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS497419A (no) * 1972-05-24 1974-01-23
JPS57188515A (en) * 1981-05-13 1982-11-19 Kyoto Yakuhin Kogyo Kk Stabilized aqueous dopamine preparation
HU188181B (en) * 1981-06-11 1986-03-28 Warner-Lambert Co,Us Process for producing salts of naphtiridine and quinoline compounds of antimicrobial activity
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren

Also Published As

Publication number Publication date
DK175494B1 (da) 2004-11-08
GR3002544T3 (en) 1993-01-25
IE59385B1 (en) 1994-02-23
IL80380A (en) 1990-11-29
HK115593A (en) 1993-11-05
KR870003786A (ko) 1987-05-04
JPS6299326A (ja) 1987-05-08
AU6432786A (en) 1987-04-30
DE3676158D1 (de) 1991-01-24
EP0219784B1 (de) 1990-12-12
FI864272A (fi) 1987-04-25
ATE59003T1 (de) 1990-12-15
ZA868057B (en) 1987-06-24
DK507886A (da) 1987-04-25
IL80380A0 (en) 1987-01-30
HUT42952A (en) 1987-09-28
EP0219784A2 (de) 1987-04-29
AU571796B2 (en) 1988-04-21
FI84555C (fi) 1991-12-27
FI84555B (fi) 1991-09-13
IE862803L (en) 1987-04-24
ES2021571B3 (es) 1991-11-16
PT83588A (en) 1986-11-01
SU1487801A3 (ru) 1989-06-15
US4957922A (en) 1990-09-18
KR940002664B1 (ko) 1994-03-28
DE3537761A1 (de) 1987-04-30
PH26419A (en) 1992-07-15
EP0219784A3 (en) 1987-11-04
DK507886D0 (da) 1986-10-23
PL262006A1 (en) 1988-10-13
FI864272A0 (fi) 1986-10-22
UA8033A1 (uk) 1995-12-26
DD252125A5 (de) 1987-12-09
CA1282006C (en) 1991-03-26
NO864022L (no) 1987-04-27
NZ218016A (en) 1989-02-24
JPH0714879B2 (ja) 1995-02-22
PL152336B1 (en) 1990-12-31
CY1729A (en) 1994-05-06
AR244085A1 (es) 1993-10-29
PT83588B (pt) 1989-05-31

Similar Documents

Publication Publication Date Title
NO864022L (no) Infusjonsopploesninger av 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-kinolin-3-karboksylsyre.
DE3574972D1 (de) 7-substituierte 1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-chinolincarbonsaeure
AU7190987A (en) 1-cyclopropyl-6, 8-difluoro-1,4-dihydro-4-oxoquinoline -3-carboxylic acid derivatives
NL300014I2 (nl) Chinolinederivaten en bereidingsprocessen hiervoor.
DE3576335D1 (de) Chinolincarbonsaeure-derivate.
NO860870L (no) Kinolonkarboksylsyrederivater.
NO862687L (no) Fremstilling av antibakterielle quinolonkarboksylsyrederivater.
ES2038128T3 (es) Preparaciones farmaceuticas de ciprofloxacina.
FR2585578B1 (fr) Canule, notamment pour cholangiogramme
NO862230D0 (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
NO166530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazin-1,4-naftalendion-derivater.
FI864736A0 (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.
MX9203502A (es) Derivados policiclicos de quinolina, naftiridina y pirazinopiridina.
ES542898A0 (es) Procedimiento de obtencion de acido 1-etil-6-fluoro-1,4-di- hidro-4-oxo-7-(1-piperazinil)-3-quinolincarboxilico
IT8421854A0 (it) Procedimento per la preparazione di acido 1-etil-6-fluoro-1,4-diidro-7-(1-piperazil)-4-oxochinolin-3-carbossilico.
ES519330A0 (es) Procedimiento para la obtencion del clorhidrato del acido del 1-etil-6-fluoro-1,4-dihidro-4-oxo-7-(1-piperazinil)-3-quinolinico.
NO851173L (no) Fremgangsmaate til fremstilling av kinolin-karboksylsyre-derivater.
IE851301L (en) Quinolinecarboxylic acid derivatives.
ATE75725T1 (de) Derivate von vorstufen von carboxylsaeuremedikamenten.
IL85549A (en) 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4 oxo-3-quinolinecarboxylic acid
NO883077D0 (no) 1-tertiaert-alkyl-substituert naftyridin- og quinolin-karboksylsyre.
IT8520346A0 (it) Derivato di 4-osso-1,3-benzodiossano.